CADTH suggests that community drug designs reimburse Hemgenix for that procedure of hemophilia B if particular problems are fulfilled.a panel of three of scientific professionals with expertise in diagnosing and dealing with individuals with hemophilia BClients hope gene therapy will result in less FIX infusions, small needle injections, much less